Inventor · disambiguated record
Roger Schofield Newton
Also filed as: NEWTON ROGER S · NEWTON ROGER SCHOFIELD
13 granted patents·16 pending applications·405 citations·filing 1994–2024
92Inventor score
Files withESPERION THERAPEUTICS INC11WARNER LAMBERT CO3ESPERVITA THERAPEUTICS INC2BISGAIER CHARLES LARRY1ESPEROVAX INC1
Top patents by PatentIndex Score
29 records- 0196US6680203B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·146 cites·32 claims
- 0295US5877022ARibozymes targeted to APO(a) RNARIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·167 cites·20 claims
- 0389US11737995B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·4 cites·20 claims
- 0485US8557835B2Statin-carboxyalkylether combinationsBISGAIER CHARLES LARRY·Filed 2007·Granted Oct 15, 2013·3 cites·11 claims
- 0582US11744816B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·8 claims
- 0682US11116739B2Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Sep 14, 2021·2 cites·1 claims
- 0780US6362236B1Inhibition of lipoprotein oxidationWARNER LAMBERT CO·Filed 1998·Granted Mar 26, 2002·54 cites·7 claims
- 0880US2025064767A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0976US2024148681A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1075US2024398746A1Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1174US12396972B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·3 claims
- 1271US6974702B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2003·Granted Dec 13, 2005·9 cites·36 claims
- 1369US10912751B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Feb 9, 2021·1 cites·13 claims
- 1468US2022110904A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1568US2014012042A1Calcium Dicarboxylate EthersWARNER LAMBERT CO·Filed 2013·Application pending·0 cites
- 1662US2005148654A1Statin-carboxyalkylether combinationsFiled 2005·Application pending·0 cites
- 1760US2003105154A1Statin-carboxyalkylether combinationsFiled 2002·Application pending·0 cites
- 1858US2004176393A1Statin-MMP inhibitor combinationsFiled 2003·Application pending·0 cites
- 1956US2005020607A1Statin-MMP inhibitor combinationsFiled 2004·Application pending·0 cites
- 2054US2002049237A1Statin-MMP inhibitor combinationsFiled 2001·Application pending·0 cites
- 2152US2004092574A1Statin-Lp(a) inhibitor combinationsFiled 2003·Application pending·0 cites
- 2251US9610324B2Apolipoprotein mixturesESPERION THERAPEUTICS INC·Filed 2013·Granted Apr 4, 2017·0 cites·60 claims
- 2348US5599706ARibozymes targeted to apo(a) mRNAFiled 1994·Granted Feb 4, 1997·10 cites·22 claims
- 2447US2002103252A1Statin-carboxyalkylether combinationsFiled 2001·Application pending·0 cites
- 2546US6492410B1Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancerWARNER LAMBERT CO·Filed 1999·Granted Dec 10, 2002·8 cites·30 claims
- 2644US2022145309A1Yeast-Based Oral VaccinationESPEROVAX INC·Filed 2020·Application pending·0 cites
- 2739US2001028895A1Methods of treating alzheimer's diseaseFiled 2001·Application pending·0 cites
- 2825US2017209402A1Carboxy-cyclopropyl undecanol compounds for treatment of liver disease and other medical disordersESPERION THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2925US2013137628A1Dimeric Oxidation-Resistant Apolipoprotein A1 VariantsNEWTON ROGER S·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roger Schofield Newton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →